Change From Baseline to 12 Week Endpoint in International Prostate Symptom Score (IPSS): Primary Analysis Baseline and 12 weeks [clinicaltrials_resource:128cb6a83ef260753aa08c74d997b2c1]
placebo tablet
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change From Baseline to 12 Week Endpoint in International Prostate Symptom Score (IPSS): Primary Analysis Baseline and 12 weeks [clinicaltrials_resource:128cb6a83ef260753aa08c74d997b2c1]
placebo tablet
Bio2RDF identifier
128cb6a83ef260753aa08c74d997b2c1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:128cb6a83ef260753aa08c74d997b2c1
measure [clinicaltrials_vocabulary:measure]
Change From Baseline to 12 Wee ...... Score (IPSS): Primary Analysis
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and 12 weeks
description
placebo tablet
identifier
clinicaltrials_resource:128cb6a83ef260753aa08c74d997b2c1
title
Change From Baseline to 12 Wee ...... Analysis Baseline and 12 weeks
@en
type
label
Change From Baseline to 12 Wee ...... cb6a83ef260753aa08c74d997b2c1]
@en